Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NSTG

NanoString Technologies (NSTG) Stock Price, News & Analysis

NanoString Technologies logo

About NanoString Technologies Stock (NASDAQ:NSTG)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.05
$0.80
52-Week Range
N/A
Volume
23.06 million shs
Average Volume
34.54 million shs
Market Capitalization
$5.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Receive NSTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoString Technologies and its competitors with MarketBeat's FREE daily newsletter.

NSTG Stock News Headlines

Big Oil’s big pivot
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
See More Headlines

NSTG Stock Analysis - Frequently Asked Questions

NanoString Technologies, Inc. (NASDAQ:NSTG) announced its quarterly earnings data on Thursday, August, 3rd. The biotechnology company reported ($0.92) EPS for the quarter, missing analysts' consensus estimates of ($0.70) by $0.22. NanoString Technologies's revenue for the quarter was up 37.1% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that NanoString Technologies investors own include Xtrackers California Municipal Bond ETF (CA), Tesla (TSLA), BlackRock (BLK), NVIDIA (NVDA), Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG) and Meta Platforms (META).

Company Calendar

Last Earnings
8/03/2023
Today
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:NSTG
Employees
550
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$159.54 million
Net Margins
-102.44%
Pretax Margin
-102.30%

Debt

Sales & Book Value

Annual Sales
$127.26 million
Price / Cash Flow
N/A
Book Value
$0.98 per share
Price / Book
N/A

Miscellaneous

Free Float
46,626,000
Market Cap
$5.07 million
Optionable
Optionable
Beta
1.24

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:NSTG) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners